Cargando…
Efficacy of Intravenous Immunoglobulin/Exchange Transfusion Therapy on Gestational Alloimmune Liver Disease
Background: Gestational alloimmune liver disease (GALD) is a rare but critical cause of neonatal liver failure. After discovering the maternal–fetal alloimmune mechanism, intravenous immunoglobulin (IVIG) with or without exchange transfusion (ET) has gradually replaced antioxidant cocktails as the f...
Autores principales: | Yeh, Pai-Jui, Huang, Shiu-Feng, Chiang, Ming-Chou, Wang, Chao-Jan, Lai, Ming-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255369/ https://www.ncbi.nlm.nih.gov/pubmed/34235125 http://dx.doi.org/10.3389/fped.2021.680730 |
Ejemplares similares
-
Intravenous Immunoglobulin Use in Hemolytic Disease Due to ABO Incompatibility to Prevent Exchange Transfusion
por: Okulu, Emel, et al.
Publicado: (2022) -
Intravenous immunoglobulin induced pancytopenia while preventing development of gestational alloimmune liver disease: A case report
por: Sarker, Minhazur, et al.
Publicado: (2022) -
Premature birth associated with a favorable course in gestational alloimmune liver disease (GALD): A case report
por: Mulzer, Linda-Marie, et al.
Publicado: (2023) -
Pediatric Liver Abscess: Trends in the Incidence, Etiology, and Outcomes Based on 20-Years of Experience at a Tertiary Center
por: Yeh, Pai-Jui, et al.
Publicado: (2020) -
Fetal and neonatal outcome in severe alloimmunization managed with intrauterine transfusion: 18-year experience in a tertiary referral hospital in China
por: Pan, Wenxu, et al.
Publicado: (2023)